M&A Update – April 18

– BLU to be acquired by GSK for $14.75 cash per share, 103.2% premium, $2.0 billion
– IRBT / AMZN UK CMA phase 1 inquiry, deadline June 16
– CIH / Fang Holdings deal closed
– ATCX / GI Partners delisting notice, closing Apr 19
– NUVA / GMED announced Glass Lewis recommends vote For
– TIG vote